scholarly journals Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

2019 ◽  
Vol 13 ◽  
Author(s):  
Renata Colombo Bonadio ◽  
Pedro Isaacsson Velho ◽  
Guilherme Nader Marta ◽  
Mirella Narda ◽  
Manoel Carlos LA Souza ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Clear Cell ◽  
Line Treatment ◽  
First Line ◽  
Real World Evidence ◽  
First Line Treatment

Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma

2012 ◽  
Vol 31 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Mary Kilonzo ◽  
Jenni Hislop ◽  
Andrew Elders ◽  
Cynthia Fraser ◽  
Donald Bissett ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects

2019 ◽  
Vol 39 (10) ◽  
pp. 5559-5564 ◽  
Author(s):  
RIIKKA-LIISA VUORINEN ◽  
NIINA PAUNU ◽  
TAINA TURPEENNIEMI-HUJANEN ◽  
TAINA REUNAMO ◽  
ANTTI JEKUNEN ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document